RCKT FY 2018 Earnings — Rocket Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

RCKTRocket Pharmaceuticals, Inc.

$538M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$330,000

Operating Income

-$71M

Net Income

-$75M

EPS (Diluted)

$-1.89

Cash Flow

Operating Cash Flow

-$54M

Free Cash Flow

-$55M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$251M

Total Liabilities

$57M

Stockholders' Equity

$194M

Cash & Equivalents

$111M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$330,000	-$204,000	-61.8%
Operating Income	-$71M	-$27M	-166.1%
Net Income	-$75M	-$29M	-152.6%